Long‐term Administration of Rapamycin Reduces Adiposity, but Impairs Glucose Tolerance in High‐Fat Diet‐fed KK/HlJ Mice
Open Access
- 11 August 2009
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 105 (3) , 188-198
Abstract
Abstract: Rapamycin is an immunosuppressant drug used to prevent organ rejection in transplant patients. In this study, we investigated the metabolic effects of rapamycin in an obese animal model, KK/HlJ mice. Mice were treated with a daily intraperitoneal injection of rapamycin at 2 mg/kg or vehicle for 42 days on a high‐fat diet. Treated mice lost body weight and adiposity, reduced weight gain and retroperitoneal and epididymal fat pads/body weight, decreased serum leptin and plasma triglyceride levels and had lower liver fat concentration. However, treated mice had higher serum insulin levels and food intake. Dissection of rapamycin‐treated mice revealed a marked reduction in fatty liver scores and fat cell size in retroperitoneal and epididymal adipocytes. Moreover, Western blot analysis revealed that rapamycin treatment resulted in decreasing adipophilin expression, as a marker of lipid accumulation, and reducing phosphorylation of mTOR downstream targets S6K1 compared to control group. Unfortunately, rapamycin‐treated animals showed a marked decline in glucose tolerance as judged by the 180‐min. area under the curve for plasma glucose levels, paralleled by increased generation of plasma reactive oxygen species. These results suggest that continual rapamycin administration may help to prevent diet‐induced obesity, while prolonged use of rapamycin may exacerbate glucose intolerance.Keywords
This publication has 63 references indexed in Scilit:
- Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic miceDiabetes, Obesity and Metabolism, 2009
- The Role of Hypothalamic Mammalian Target of Rapamycin Complex 1 Signaling in Diet-Induced ObesityJournal of Neuroscience, 2008
- Role of the PI3-kinase/mTor pathway in the regulation of the stearoyl CoA desaturase (SCD1) gene expression by insulin in liverJournal of Cell Communication and Signaling, 2007
- mTOR Complex1–S6K1 signaling: at the crossroads of obesity, diabetes and cancerTrends in Molecular Medicine, 2007
- Adipophilin increases triglyceride storage in human macrophages by stimulation of biosynthesis and inhibition of β‐oxidationThe FEBS Journal, 2006
- Immunosuppression and Metabolic Syndrome in Renal Transplant RecipientsMetabolic Syndrome and Related Disorders, 2004
- Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivityNature, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in MiceCirculation, 2003
- Rapamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD miceClinical and Experimental Immunology, 1992